Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cardiovascular Research

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2007.06.027PMID 17678635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium.

  2005cited by this paper
• Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.

  2005cited by this paper
• Dynamic GATA Factor Interplay at a Multicomponent Regulatory Region of the GATA-2 Locus*

  2005cited by this paper
• Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.

  2005cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production.

  2005cited by this paper
• Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo.

  2005cited by this paper
• Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator–Activated Receptor-γ Both Induce Cardiac Hypertrophy in Mice

  2005cited by this paper
• Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance

  2005cited by this paper
• Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

  2004influential reference
• Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation.

  2004cited by this paper
• Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance?

  2004cited by this paper
• Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.

  2003cited by this paper
• Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

  2003cited by this paper
• Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle

  2003cited by this paper
• Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs.

  2003cited by this paper
• Muscle-specific Pparg deletion causes insulin resistance

  2003influential reference
• Metallothionein Protection against Alcoholic Liver Injury through Inhibition of Oxidative Stress

  2002influential reference
• Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

  2002cited by this paper
• Animal models for mitochondrial disease.

  2002cited by this paper
• Respiratory chain complex I deficiency.

  2001cited by this paper
• Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis.

  2001cited by this paper
• Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy

  2001cited by this paper
• PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development

  1999cited by this paper
• PPAR gamma is required for placental, cardiac, and adipose tissue development.

  1999cited by this paper
• An Intronic NF-kappaB Element Is Essential for Induction of the Human Manganese Superoxide Dismutase Gene by Tumor Necrosis Factor-alpha and Interleukin-1beta

  1999cited by this paper
• Respiratory chain complex I deficiency

  1999cited by this paper
• Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese.

  1999cited by this paper
• Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice.

  1999cited by this paper
• Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid.

  1999cited by this paper
• Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.

  1997cited by this paper
• Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.

  1996cited by this paper
• Requirement for superoxide in excitotoxic cell death.

  1996cited by this paper
• Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

  1995cited by this paper
• In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation.

  1994cited by this paper
• Study of 5'-flanking region of human Cu/Zn superoxide dismutase.

  1994cited by this paper
• Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA.

  1992cited by this paper
• Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR).

  1991cited by this paper

• Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failure

  2026cites this paper
• Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders

  2025cites this paper
• Fatty acid metabolism suppresses neonatal cardiomyocyte proliferation by increasing PDK4 and HMGCS2 expression through PPARδ

  2025cites this paper
• Molecular Insights into Oxidative-Stress-Mediated Cardiomyopathy and Potential Therapeutic Strategies

  2025cites this paper
• Preventive effect of siphonaxanthin, a carotenoid from green algae, against diabetic nephropathy and lipid metabolism insufficiency in skeletal muscle.

  2025cites this paper
• Lipid Droplets: Emerging therapeutic targets for age-related metabolic diseases.

  2025cites this paper
• Golden Tomato Juice Enhances Hepatic PPAR-α Expression, Mitigates Metabolic Dysfunctions and Influences Redox Balance in a High-Fat-Diet Rat Model

  2024cites this paper
• Involvement of Nrf2-PPAR-γ signaling in Coenzyme Q10 protecting effect against methotrexate-induced testicular oxidative damage.

  2024cites this paper
• Transcriptional control of cardiac energy metabolism in health and disease: Lessons from animal models.

  2024cites this paper
• Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation

  2024cites this paper
• N-acetylcysteine alleviates arsenic trioxide-induced reductions in hepatic catalase gene expression both in vitro and in vivo.

  2024cites this paper
• Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128

  2024influential citation
• The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective

  2023cites this paper
• Angelica sinensis polysaccharide improves mitochondrial metabolism of osteoarthritis chondrocytes through PPARγ/SOD2/ROS pathways

  2023cites this paper
• Ectopic Lipid Accumulation Correlates with Cellular Stress in Rabbit Blastocysts from Diabetic Mothers

  2023influential citation
• Epicardial adipose tissue and cardiac lipotoxicity: A review.

  2023cites this paper
• Docosahexaenoic Acid as Master Regulator of Cellular Antioxidant Defenses: A Systematic Review

  2023cites this paper
• Fenofibrate attenuates the cytotoxic effect of cisplatin on lung cancer cells by enhancing the antioxidant defense system in vitro

  2023cites this paper
• Effect of PPARγ on oxidative stress in diabetes-related dry eye.

  2023cites this paper
• Exosomal STIMATE derived from type II alveolar epithelial cells controls metabolic reprogramming of tissue-resident alveolar macrophages

  2023cites this paper
• Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient

  2022cites this paper
• Palmitate Induces Mitochondrial Energy Metabolism Disorder and Cellular Damage via the PPAR Signaling Pathway in Diabetic Cardiomyopathy

  2022cites this paper
• Sarcomere maturation: function acquisition, molecular mechanism, and interplay with other organelles

  2022cites this paper
• Circadian Control of Mitochondria in Reactive Oxygen Species Homeostasis

  2022cites this paper
• Circadian rhythmicity of the thioredoxin system in cultured murine peritoneal macrophages.

  2022cites this paper
• From Food to Genes: Transcriptional Regulation of Metabolism by Lipids and Carbohydrates

  2021cites this paper
• The circadian clock and metabolic homeostasis: entangled networks

  2021cites this paper
• A meta-analysis of microRNA expression profiling studies in heart failure

  2021cites this paper
• Effects of dietary pyridoxine on the skin immunity, tight junctions, antioxidants and apoptosis of grass carp ( Ctenopharyngodon idella ) infected with Aeromonas hydrophila

  2021cites this paper
• Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer

  2021cites this paper
• Brain‑derived neurotrophic factor and nitric oxide contribute to protective effects of rosiglitazone on learning and memory in hypothyroid rats.

  2021cites this paper
• PPAR control of metabolism and cardiovascular functions

  2021cites this paper
• Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway

  2021cites this paper
• Chronic Low-Dose Alcohol Consumption Attenuates Post-Ischemic Inflammation via PPARγ in Mice

  2021cites this paper
• Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug

  2021cites this paper
• The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy

  2020cites this paper
• Effect of p53 activation on experimental right ventricular hypertrophy

  2020cites this paper
• Effects of PPAR-γ in the Myocardium on the Development of Ventricular Septation

  2020cites this paper
• Circadian Clock and Sirtuins in Diabetic Lung: A Mechanistic Perspective

  2020cites this paper
• The Involvement of Anti-Oxidative Response and Mitochondrial Dynamics in the Pathogenesis of Friedreich’s Ataxia: Relevance to the Development of Future Therapeutics

  2020cites this paper
• Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review

  2020cites this paper
• Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm

  2020influential citation
• The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.

  2020cites this paper
• Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites

  2020cites this paper
• The antioxidative enzyme SOD2 is important for physiological persistence of corpora lutea in lynxes

  2020cites this paper
• Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity

  2020cites this paper
• Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.

  2020cites this paper
• Circadian Mutant Mice with Obesity and Metabolic Syndrome are Resilient to Cardiovascular Disease.

  2020cites this paper
• Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension

  2019cites this paper
• Cardioprotective Regimen of Adaptation to Chronic Hypoxia Diversely Alters Myocardial Gene Expression in SHR and SHR-mtBN Conplastic Rat Strains

  2019cites this paper
• Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism.

  2019cites this paper
• Astaxanthin Prevents Decreases in Superoxide Dismutase 2 Level and Superoxide Dismutase Activity in Helicobacter pylori-infected Gastric Epithelial Cells

  2019cites this paper
• Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors

  2019cites this paper
• The influence of alkaloids on oxidative stress and related signaling pathways.

  2019cites this paper
• Pioglitazone reversed the fructose-programmed astrocytic glycolysis and oxidative phosphorylation of female rat offspring.

  2019cites this paper
• The Role of Peroxisome Proliferator-Activated Receptor γ in Mediating Cardioprotection Against Ischemia/Reperfusion Injury

  2018cites this paper
• PPARδ, a Potential Therapeutic Target for Heart Disease

  2018cites this paper
• Role of GPx3 in PPAR&ggr;‐induced protection against COPD‐associated oxidative stress

  2018cites this paper
• Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases

  2018cites this paper
• Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury

  2017cites this paper
• Effects of intermittent ladder-climbing exercise training on mitochondrial biogenesis and endoplasmic reticulum stress of the cardiac muscle in obese middle-aged rats

  2017cites this paper
• The Effects of PPARβ on High Fat Diet Induced Mitochondrial H2O2 Emission and GLUT4 Expression in Skeletal Muscle

  2017cites this paper
• Nuclear Receptors and the Adaptive Response of the Heart

  2017cites this paper
• Sub-cellular localization specific SUMOylation in the heart.

  2017cites this paper
• PPARs modulate cardiac metabolism and mitochondrial function in diabetes

  2017cites this paper
• Peroxisome proliferator-activated receptors as therapeutic targets for heart failure.

  2017cites this paper
• Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia: An Impaired Nrf2 Response Mediated via Upregulation of Keap1 and Activation of the Gsk3β Axis.

  2017cites this paper
• Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease

  2017cites this paper
• The stress-response molecule NR4A1 resists ROS-induced pancreatic β-cells apoptosis via WT1.

  2017cites this paper
• The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.

  2017cites this paper
• Phytochemicals as inhibitors of NF‐&kgr;B for treatment of Alzheimer's disease

  2017cites this paper
• Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts

  2017cites this paper
• Gr upSM Functioning of the PPAR Gamma and its Effect on Cardiovascular and Metabolic Diseases

  2017influential citation
• Methyl metabolism in obesity-related cardiac remodeling

  2016cites this paper
• The role of PPARgamma in cardiovascular diseases.

  2016cites this paper
• Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats

  2016cites this paper
• Effects of Ranolazine on Astrocytes and Neurons in Primary Culture

  2016cites this paper
• Gamma-Glutamylcysteine Ethyl Ester Protects against Cyclophosphamide-Induced Liver Injury and Hematologic Alterations via Upregulation of PPARγ and Attenuation of Oxidative Stress, Inflammation, and Apoptosis

  2016cites this paper
• Pioglitazone increases PGC1-α signaling within chronically ischemic myocardium

  2016cites this paper
• Mitochondrial H2O2 in Lung Antigen-Presenting Cells Blocks NF-κB Activation to Prevent Unwarranted Immune Activation.

  2016cites this paper
• PPARγ-PI3K/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin.

  2015cites this paper
• Maintaining ancient organelles: mitochondrial biogenesis and maturation.

  2015cites this paper
• Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice

  2015cites this paper
• Association between cardiac changes and stress, and the effect of peroxisome proliferator-activated receptor-γ on stress-induced myocardial injury in mice

  2015cites this paper
• PPARs: Protectors or Opponents of Myocardial Function?

  2015cites this paper
• Cardiomyocyte lipotoxicity is mediated by Il-6 and causes down-regulation of PPARs.

  2015cites this paper
• Negative Regulation of Leptin-induced Reactive Oxygen Species (ROS) Formation by Cannabinoid CB1 Receptor Activation in Hypothalamic Neurons

  2015cites this paper
• Association between Cardiac Changes and Stress , and the Effect of Peroxisome Proliferator-activated Receptor-γ on Stress-induced Myocardial Injury in Mice *

  2015cites this paper
• Mitochondrial Dysfunction in Stem Cell Aging

  2015cites this paper
• Mitochondrial Biogenesis and Maturation

  2015cites this paper
• Review of the Role of PPAR Gamma and Agonists in the Development of Heart

  2015cites this paper
• ABC transporters as therapeutic targets for liver fibrosis

  2014influential citation
• Rosiglitazone Synergizes the Neuroprotective Effects of Valproic Acid Against Quinolinic Acid-Induced Neurotoxicity in Rats: Targeting PPARγ and HDAC Pathways

  2014cites this paper
• Effect of some Neuroprotective drugs on certain biochemical parameters during experimental brain ischaemia.

  2014cites this paper
• Impact des ligands de PPARs, et leurs dérivés, sur les cellules cancéreuses coliques humaines : modifications des statuts redox et glycolytique

  2014cites this paper
• Transcriptional Control of Antioxidant Defense by the Circadian Clock

  2014cites this paper
• The Effect of Endurance Exercise Training on Inflammatory Cytokines, Apoptosis, and FOXO Expression in Adipose Tissue of Hypertensive Rats

  2014cites this paper
• A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

  2014cites this paper
• Antioxidant adaptations in liver fibrogenesis

  2014cites this paper
• Conditional Deletion of Cardiomyocyte Peroxisome Proliferator-Activated Receptor &ggr; Enhances Myocardial Ischemia-Reperfusion Injury in Mice

  2014cites this paper